Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027

36E79725R0060

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Radha Pharmaceuticals Inc.

$7,450,452.60 on the award notice, January 28, 2026, contract 36E79726D0013

Description

As published on SAM.gov.

n/a

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Radha Pharmaceuticals Inc.
UEI
C1S5SQ88KY67
CAGE
8PNH3
Vendor location
Hauppauge, NY
Contract
36E79726D0013
Obligated
$0.00, potential $7,450,453
Actions
1 between January 28, 2026 and January 28, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Hydralazine HCL Tablets with Radha Pharmaceuticals with Four ONE-YEAR Options
Match
award number 36E79726D0013 equals the contract number; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 21, 2025

    Presolicitation

    Hydralazine RFP

    Due November 12, 2025 at 3:30 PM EST. SAM.gov, notice 91599835cbc94ed99ad7bfedc2124331

  2. October 23, 2025

    Solicitation, originally presolicitation

    Hydralazine RFP

    Due November 6, 2025 at 3:30 PM EST. SAM.gov, notice 3a0457f59dc3410eaad3c87cd7d3b27b

  3. November 5, 2025

    Solicitation

    Hydralazine RFP

    Due November 13, 2025 at 3:30 PM EST. SAM.gov, notice 409f56de7eeb483b86c708b34b48fb5e

  4. February 4, 2026

    Award notice

    Awarded to Radha Pharmaceuticals Inc. Hauppauge 11788 for $7,450,453. SAM.gov, notice 10ecccbc77834712bed0155e4280a9a1

Points of contact

Also open from this buyer